Pudong Investment Center, Shanghai, and Heyuan Biotech have established a venture capital partnership.

The Qichacha APP shows that recently, Shanghai Heyuan Hongsheng Phase I Venture Capital Partnership was established with a capital contribution of 500 million yuan. The business scope includes: venture capital. Qichacha's equity penetration shows that this partnership is jointly held by Heyuan Biotechnology, Shanghai Pudong Leading Area Investment Center, and Shanghai Guotou Xian Dao Biomedical Private Investment Fund Partnership, among others.